February 10, 2026
Insilico Medicine Leads Hong Kong Biotech IPO with AI Drug Discovery Prowess

Insilico Medicine, a clinical-stage drug discovery and development company driven by artificial intelligence (AI), has made history by being listed…
Read More

About The Author

Leave a Reply

Your email address will not be published. Required fields are marked *